CC
Corton Capital Portfolio holdings
AUM
$85.9M
This Quarter Return
+22.21%
1 Year Return
+50.75%
3 Year Return
+186.03%
5 Year Return
–
10 Year Return
–
AUM
$314M
AUM Growth
+$314M
(+59%)
Cap. Flow
+$78.1M
Cap. Flow
% of AUM
24.87%
Top 10 Holdings %
Top 10 Hldgs %
24.41%
Holding
668
New
255
Increased
199
Reduced
105
Closed
108
Top Buys
| 1 |
Merck
MRK
|
$1.61M |
| 2 |
Cytokinetics
CYTK
|
$1.18M |
| 3 |
G-III Apparel Group
GIII
|
$1.16M |
| 4 |
Duke Energy
DUK
|
$1.04M |
| 5 |
First Citizens BancShares
FCNCA
|
$1.02M |
Top Sells
| 1 |
Coinbase
COIN
|
$1.19M |
| 2 |
NextEra Energy, Inc.
NEE
|
$1.02M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$971K |
| 4 |
Uber
UBER
|
$886K |
| 5 |
Carvana
CVNA
|
$866K |
Sector Composition
| 1 | Technology | 35.85% |
| 2 | Healthcare | 14.88% |
| 3 | Consumer Discretionary | 9.96% |
| 4 | Financials | 8.64% |
| 5 | Industrials | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Petco
WOOF
$1.01B
| $90.1K | 0.03% |
28,502
-6,534
| -19% | -$20.6K |
|
552
Custom Truck One Source
CTOS
$1.38B
| $85.7K | 0.03% |
+13,870
| New | +$85.7K |
|
|
NPKI
553
NPK International Inc.
NPKI
$863M
| $78.6K | 0.03% |
+11,839
| New | +$78.6K |
|
554
PDS Biotechnology
PDSB
$58.3M
| $75.3K | 0.02% |
15,150
-6,941
| -31% | -$34.5K |
|
555
Caribou Biosciences
CRBU
$175M
| $73.1K | 0.02% |
+12,749
| New | +$73.1K |
|
|
CANO
556
DELISTED
Cano Health, Inc.
CANO
| $71.1K | 0.02% |
+12,113
| New | +$71.1K |
|
557
Century Casinos
CNTY
$79.9M
| $66.4K | 0.02% |
+13,599
| New | +$66.4K |
|
|
EGRX
558
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $62.3K | 0.02% |
+11,917
| New | +$62.3K |
|
559
Sonder
SOND
$25.6M
| $58.1K | 0.02% |
+17,149
| New | +$58.1K |
|
560
Design Therapeutics
DSGN
$326M
| $33.4K | 0.01% |
12,607
-14,527
| -54% | -$38.5K |
|
561
Getty Images
GETY
$738M
| – | – |
-16,864
| Closed | -$109K |
|
562
Monte Rosa Therapeutics
GLUE
$300M
| – | – |
-14,460
| Closed | -$69.3K |
|
563
Grocery Outlet
GO
$1.81B
| – | – |
-7,471
| Closed | -$216K |
|
564
American Airlines Group
AAL
$8.69B
| – | – |
-26,661
| Closed | -$342K |
|
565
AbbVie
ABBV
$373B
| – | – |
-2,157
| Closed | -$322K |
|
566
Aclaris Therapeutics
ACRS
$219M
| – | – |
-14,916
| Closed | -$102K |
|
567
Adeia
ADEA
$1.62B
| – | – |
-21,006
| Closed | -$224K |
|
568
Alignment Healthcare
ALHC
$3.3B
| – | – |
-36,074
| Closed | -$250K |
|
569
Allogene Therapeutics
ALLO
$255M
| – | – |
-12,628
| Closed | -$40K |
|
570
Altimmune
ALT
$325M
| – | – |
-10,202
| Closed | -$26.5K |
|
|
AMED
571
DELISTED
Amedisys
AMED
| – | – |
-2,261
| Closed | -$211K |
|
572
AngioDynamics
ANGO
$424M
| – | – |
-11,927
| Closed | -$87.2K |
|
573
Apellis Pharmaceuticals
APLS
$3.57B
| – | – |
-6,083
| Closed | -$231K |
|
574
Arhaus
ARHS
$1.6B
| – | – |
-10,073
| Closed | -$93.7K |
|
575
Arrowhead Research
ARWR
$3.46B
| – | – |
-12,324
| Closed | -$331K |
|